Latest Drug Approvals news
FDA Approves Myqorzo for Symptomatic Obstructive Hypertrophic Cardiomyopathy
posted January 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Jascayd for Progressive Pulmonary Fibrosis
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Once-Daily Pill Form of Wegovy for Weight Loss
posted December 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Rybrevant Faspro for EGFR-Mutated Non-Small Cell Lung Cancer
posted December 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
